All News

Torsemide is an alternative for patients who skip loop diuretic treatment due to concerns of excessive urination, as well as individuals with chronic kidney disease.

Pharmacists should educate themselves about the options available to help patients manage this bacterium that causes severe diarrhea and colitis.

According to the study, lineage plasticity—the shift in castration-resistant prostate cancers from resembling glandular cells to neuroendocrine cells—may potentially be overcome through the use of bromodomain and extra-terminal (BET) protein inhibitors.

Each drug formulary has the evidence to support why a medication is included or excluded from a health plan and explaining that to the patient is difficult.

The trial, in phase 3, is the first to report data comparing a neoadjuvant anti-HER2 based regimen with or without the anti-PD-L1 antibody, atezolimumab, in patients with high-risk, HER2-positive early breast cancer.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Pharmacists can educate patients about a pair of new treatment options for multiple myeloma approved by the FDA in March 2021.

These financial challenges can include difficulty paying medical bills or the inability to pay them at all, high financial distress, cost-related medication non-adherence, food insecurity, and delayed or foregone care due to cost.

Pharmacists can implement several recommendations into their practice, regardless of the setting.

Earlier this year, the FDA granted accelerated approval to tepotinib (Tepmetko, EMD Serono Inc) for the treatment of adults with metastatic non-small cell lung cancer who are harboring MET exon 14 skipping alterations.

Prior to this research, it was known that genetically removing the POLQ protein killed cells with BRCA gene defects, but no drug had been identified that prevented POLQ from functioning.

Jordan Tishler, MD, president of the Association of Cannabis Specialists and faculty at Harvard Medical School, discusses the importance of unbiased, knowledgeable providers being present at the site of sale of cannabis in order to provide accurate information on the appropriate use of medical cannabis for certain medical conditions.

Intravenous immunoglobulin is a cornerstone in autoimmune disease treatment.

The findings showed that 63 of the 9119 patients with severe COVID-19 infection contracted the virus a second time, with an average reinfection period of 116 days.

Positive topline results have been published from a phase 3 trial assessing the CD-19 directed CAR T cell therapy lisocabtagene maraleucel as a second-line treatment in adults with relapsed or refractory LBCL.

Popular among European royalty, the consumption of human brain emerged in the 17th century as a cure to ailments of the mind.

The omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid were applied first in high doses to lab-grown neurons and then in patients to understand the mechanism by which they reduce inflammation and depression.

Astepro Allergy is the first steroid-free antihistamine of its kind to be available without a prescription.

Researchers found that men with a family history of prostate cancer reached the screening risk threshold up to 12 years earlier than the general population.

Specialty medications should not be defined by their cost and should instead be defined by their efficacy.

Phase 2 clinical trial results assessing sotorasib in previously treated patients with NSCLC showed that the drug presented a median OS of 12.5 months among 124 patients.

The FDA recently approved the amyloid beta-directed antibody indicated for the treatment of the progressive disease.

Pharmacists play an important role in assisting with hypertension treatment by helping to modify blood pressure therapies when patients experience adverse effects or helping if a patient has difficulty remembering to take their medications.

The findings led to the FDA accepting the supplemental Biologics License Application and Priority Review designation for treatment, according to a Gilead press release.

The study authors examined data from the Health and Retirement Study, which included 2496 individuals who were at least 51 years of age.

Results of various studies show potentially promising clinical benefits associated with the use of supplementation in individuals who have the virus.